Authors:
Lankhuizen, IM
van Veghel, R
Saxena, PR
Schoemaker, RG
Citation: Im. Lankhuizen et al., Vascular and renal effects of vasopressin and its antagonists in consciousrats with chronic myocardial infarction; evidence for receptor shift, EUR J PHARM, 423(2-3), 2001, pp. 195-202
Authors:
Bijsterbosch, MK
Rump, ET
De Vrueh, RLA
Dorland, R
van Veghel, R
Tivel, KL
Biessen, EAL
van Berkel, TJC
Manoharan, M
Citation: Mk. Bijsterbosch et al., Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation, NUCL ACID R, 28(14), 2000, pp. 2717-2725
Authors:
Lankhuizen, IM
van Veghel, R
Saxena, PR
Schoemaker, RG
Citation: Im. Lankhuizen et al., [Arg(8)]-vasopressin-induced responses on coronary and mesenteric arteriesof rats with myocardial infarction: The effects of V-1a- and V-2-receptor antagonists, J CARDIO PH, 36(1), 2000, pp. 38-44
Authors:
de Vrueh, RLA
Rump, ET
van de Bilt, E
van Veghel, R
Balzarini, J
Biessen, EAL
van Berkel, TJC
Bijsterbosch, MK
Citation: Rla. De Vrueh et al., Carrier-mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to parenchymal liver cells: a novel therapeutic approach for hepatitis B, ANTIM AG CH, 44(3), 2000, pp. 477-483
Authors:
Rump, ET
de Vrueh, RLA
Manoharan, M
Waarlo, IHE
van Veghel, R
Biessen, EAL
van Berkel, TJC
Bijsterbosch, MK
Citation: Et. Rump et al., Modification of the plasma clearance and liver uptake of steroid ester-conjugated oligodeoxynucleotides by association with (lactosylated) low-density lipoprotein, BIOCH PHARM, 59(11), 2000, pp. 1407-1416
Authors:
Fechner, H
Haack, A
Wang, H
Wang, X
Eizema, K
Pauschinger, M
Schoemaker, RG
van Veghel, R
Houtsmuller, AB
Schultheiss, HP
Lamers, JMJ
Poller, W
Citation: H. Fechner et al., Expression of Coxsackie adenovirus receptor and alpha(v)-integrin does notcorrelate with adenovector targeting in vivo indicating anatomical vector barriers, GENE THER, 6(9), 1999, pp. 1520-1535